newsfilter
← Latest News
GlobeNewswire·

HilleVax Announces Pricing of Public Offering of Common Stock

BOSTON, Sept. 19, 2023 (GLOBE NEWSWIRE) -- HilleVax, Inc. (NASDAQ:HLVX), a clinical-stage biopharmaceutical company focused on developing and commercializing novel vaccines, today announced the pricing of its public